oseltamivir has been researched along with triazoles in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eyanagi, R; Imoto, M; Kuroki, H; Nishimura, S; Shimeno, H; Soeda, S; Toda, A; Uchiyama, H; Watanabe, S | 1 |
| Haselhorst, T; McAtamney, S; Mohan, S; Pinto, BM; von Itzstein, M | 1 |
| Christmann, M; Vaxelaire, C; Winter, P | 1 |
| Choi, SH; Hong, SB; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lee, SO; Lim, CM; Woo, JH | 1 |
| Chen, J; Cheng, H; Cheng, YS; Ding, K; Lin, MI; Liu, J; Liu, Y; Lu, X; Tu, Z; Wan, J; Xu, Y | 1 |
| Adabala, PJ; Bance, N; LeGresley, EB; Niikura, M; Pinto, BM | 1 |
| Cecchetti, V; Cruciani, G; Desantis, J; Goracci, L; Loregian, A; Manfroni, G; Massari, S; Mercorelli, B; Muratore, G; Nannetti, G; Palù, G; Sabatini, S; Tabarrini, O | 1 |
| Hiromura, M; Honda, S; Inoue, K; Kosako, K; Kuroki, H; Shiratani, T; Soeda, S; Toda, A; Uchiyama, H | 1 |
| Boechat, Fda C; Brozeguini, L; Cunha, AC; de Souza, MC; Faro, LV; Ferreira, VF; Fintelman-Rodrigues, N; Forezi, Lda S; Marques, IP; Nogueira, CM; Riscado, CS; Sacramento, CQ; Sagrillo, FS; Santos-Filho, O; Souza, TM | 1 |
9 other study(ies) available for oseltamivir and triazoles
| Article | Year |
|---|---|
The stimulatory effects of caffeine with oseltamivir (Tamiflu) on light-dark behavior and open-field behavior in mice.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Antiviral Agents; Caffeine; Darkness; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Exploratory Behavior; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; Haloperidol; Male; Mice; Motor Activity; Neurotransmitter Agents; Oseltamivir; Pyrimidines; Random Allocation; Triazoles; Xanthines | 2010 |
Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
Topics: Antiviral Agents; Catalytic Domain; Influenza A virus; Magnetic Resonance Spectroscopy; Models, Molecular; Neuraminidase; Oseltamivir; Protein Binding; Stereoisomerism; Triazoles; Virion | 2010 |
One-pot reactions accelerate the synthesis of active pharmaceutical ingredients.
Topics: Biphenyl Compounds; Catalysis; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Oseltamivir; Pharmaceutical Preparations; Stereoisomerism; Triazoles | 2011 |
Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antiviral Agents; Fatal Outcome; Humans; Immunocompetence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Male; Oseltamivir; Pyrimidines; Triazoles; Voriconazole | 2012 |
Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein.
Topics: Amantadine; Amides; Animals; Antiviral Agents; Cell Line; Dogs; Drug Design; Drug Resistance, Viral; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Models, Molecular; Nucleoproteins; Oseltamivir; Piperazines; Structure-Activity Relationship; Triazoles; Viral Core Proteins; Viral Plaque Assay; Virus Replication | 2012 |
Exploitation of the catalytic site and 150 cavity for design of influenza A neuraminidase inhibitors.
Topics: Antiviral Agents; Catalytic Domain; Drug Design; Influenza A virus; Neuraminidase; Oseltamivir; Triazoles | 2013 |
A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits.
Topics: Animals; Antiviral Agents; Dogs; Drug Resistance, Viral; HEK293 Cells; Humans; Influenza A virus; Influenza B virus; Madin Darby Canine Kidney Cells; Models, Molecular; Oseltamivir; Protein Subunits; Pyrimidines; RNA-Dependent RNA Polymerase; Structure-Activity Relationship; Triazoles; Viral Proteins | 2015 |
Effect of adenosine system in the action of oseltamivir on behavior in mice.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Antiviral Agents; Behavior, Animal; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Neuraminidase; Oseltamivir; Phenethylamines; Pyrimidines; Receptors, Adenosine A2; Triazoles; Walking | 2015 |
1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
Topics: Antiviral Agents; Drug Design; Drug Resistance, Viral; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Molecular Docking Simulation; Neuraminidase; Oseltamivir; Quinolones; Triazoles | 2015 |